Key result
Postoperative plasma kynurenic acid is linked to ~7.4-fold higher odds of AKI after cardiac surgery.
Why the study?
The maze procedure for atrial fibrillation might be an independent risk factor for postoperative acute kidney injury, and the metabolic alterations associated with AKI following maze-inclusive cardiac surgery needed investigation.
Does untargeted metabolomic profiling identify metabolic alterations and candidate biomarkers associated with postoperative acute kidney injury in patients undergoing the maze procedure with concomitant cardiac surgery?
Cohort (n=50)
No
Does untargeted metabolomic profiling identify metabolic alterations and candidate biomarkers associated with postoperative acute kidney injury in patients undergoing the maze procedure with concomitant cardiac surgery?
Untargeted metabolomics revealed that upregulation of the tryptophan pathway, specifically kynurenic acid at 24 hours post-surgery, is strongly and independently associated with acute kidney injury following maze-inclusive cardiac surgery.
Answers are grounded in this paper and cite their sources.
May support early AKI risk stratification post-maze surgery; leaves open causal role and need for prospective validation.
BACKGROUND: The maze procedure is considered as the standard surgical treatment for atrial fibrillation and might be an independent risk factor for postoperative acute kidney injury (AKI). This study aimed to investigate the metabolic alterations associated with AKI following maze-inclusive cardiac surgery using untargeted metabolomics. METHODS: We prospectively enrolled 50 patients who underwent the maze procedure with concomitant cardiac surgery. AKI was diagnosed as an absolute increase in serum creatinine level of ≥ 0.3 mg/dL from baseline within 48 hours, or a ≥ 50% increase in serum creatinine within 7 days after surgery. Plasma samples were collected in operation and 24 hours after surgery, and untargeted metabolomic analysis was performed. Differential metabolites were identified and subjected to pathway enrichment analysis. Clinical variables and related metabolites were analyzed to elucidate relationship with AKI. RESULTS: The concomitant surgeries were valve surgeries in 37 patients, followed by coronary artery (8 patients), and aorta (5 patients). Postoperative AKI occurred in 23 patients (46%). Metabolomic profiling revealed upregulation of tryptophan metabolism in AKI patients, with five candidate metabolites implicated. Among them, kynurenic acid exhibited the most significant metabolite associated with AKI, with an area under the receiver operating characteristic curve of 0.93. Multivariable logistic regression analysis identified kynurenic acid as independent possible predictors of AKI. CONCLUSION: Tryptophan metabolism is significantly upregulated in patients with AKI after maze-inclusive cardiac surgery. Kynurenic acid presumed in this study represents as candidate metabolite of postoperative AKI, providing an opportunity to gain insight into the underlying pathophysiology through further targeted metabolomics. TRIAL REGISTRATION: Clinical Research Information Service Identifier: KCT0011192.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) conducted a cohort in Atrial fibrillation undergoing the maze procedure with concomitant cardiac surgery (n=50). Elevated plasma kynurenic acid (tryptophan metabolism upregulation) at 24 hours post-maze cardiac surgery vs. Lower plasma kynurenic acid / No postoperative AKI was evaluated on Postoperative acute kidney injury (KDIGO criteria: serum creatinine increase ≥ 0.3 mg/dL within 48 hours or ≥ 50% increase within 7 days) (OR 7.36, 95% CI 2.04-112.48, p=<0.001). Plasma kynurenic acid peak intensity at 24 hours was independently associated with postoperative acute kidney injury after maze-inclusive cardiac surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: